Back
Analog Devices 10K Form
Sell
46
ADI
Analog Devices
Last Price:
175.41
Seasonality Move:
3.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2022-11-22 | 10K | ADI/Analog Devices Annual |
2021-12-03 | 10K | ADI/Analog Devices Annual |
2020-11-24 | 10K | ADI/Analog Devices Annual |
2020-08-19 | 10Q | ADI/Analog Devices Quarterly |
2020-05-20 | 10Q | ADI/Analog Devices Quarterly |
2020-02-19 | 10Q | ADI/Analog Devices Quarterly |
Receive ADI News And Ratings
See the #1 stock for the next 7 days that we like better than ADI
ADI Financial Statistics
Sales & Book Value
Annual Sales: | $12.01B |
---|---|
Cash Flow: | $817.88M |
Price / Cash Flow: | 24.24 |
Annual Sales: | $72.05 |
Price / Book: | 2.44 |
Profitability
EPS (TTM): | 7.36000 |
---|---|
Net Income (TTM): | $3.75B |
Gross Margin: | $7.53B |
Return on Equity: | 10.33% |
Return on Assets: | 7.51% |
Analog Devices Earnings Forecast
Key Analog Devices Financial Ratios
- The Gross Profit Margin over the past 39 years for ADI is 62.70%.
- The Selling, General & Administrative Expenses for ADI have been equal to 10.54% of Gross Profit Margin.
- The Research & Development expenses have been 14.15% of Revenue.
- The Interest Expense is 7.29% of Operating Income.
- The Net Earning history of ADI is 22.88% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 22 years.
Analog Devices Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Semiconductors |
Sector: | Technology |
Current Symbol: | ADI |
CUSIP: | 032654 |
Website: | analog.com |
Debt
Debt-to-Equity Ratio: | 0.19 |
---|---|
Current Ratio: | 1.71 |
Quick Ratio: | 0.98 |
Price-to-Earnings
Trailing P/E Ratio: | 33.42 |
---|---|
Forward P/E Ratio: | 20.68 |
ADI Technical Analysis vs Fundamental Analysis
Sell
46
Analog Devices (ADI)
is a Sell
Is Analog Devices a Buy or a Sell?
-
Analog Devices stock is rated a Sell
The current Analog Devices [ADI] share price is $175.48. The Score for ADI is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.